NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
Back to search
Official data from USPTO
MAXIM BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MAXIM BIOMEDICAL
ST13
US500000097267407Class
42
Filing
97267407
Registration
7383751
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/14/2024
Trademark type
Word
Nice classes
42
Filing date
02/15/2022
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/29/2005
First use in commerce
04/29/2005
Drawing code
4
Owner type
03
Owner location
Rockville, MD, US
Examiner
CARLYLE, SHAUNIA P
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Maxim Biomedical, Inc.
Representatives
Neha Bhalani CHIESA SHAHINIAN & GIANTOMASI PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
scientific research and development; product research and development in the field of in vitro medical deviceslateral flow assays and enzyme-linked immunosorbent assays
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/20/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/08/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/02/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2022
CNSL
SUSPENSION LETTER WRITTEN
09/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/19/2022
GNRT
NON-FINAL ACTION E-MAILED
07/19/2022
CNRT
NON-FINAL ACTION WRITTEN
07/19/2022
DOCK
ASSIGNED TO EXAMINER
07/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2022
NWAP
NEW APPLICATION ENTERED
02/18/2022
Continuous trademark protection
Get notified about every new filing that threatens MAXIM BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.